Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
A groundbreaking approach to cancer treatment
A number of breakthrough discoveries for Race Oncology's (ASX:RAC) drug Zantrene® over the past 18 months has seen the company evolve its strategy and clinical programs in order to maximise these opportunities. What does the future for Race look like?
Island Pharmaceuticals discuss the Dengue Fever pandemic
Dengue fever is a massive pandemic that continues to spread beyond geographical limits, with 400 million people affected each year. Island Pharmaceuticals (ASX: ILA) is at the forefront of the battle. Here, CEO David Foster talks about the issue:
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
IR Department celebrates International Women's Day 2022
IR Department celebrates International Women's Day 2022
Today is International Women’s Day #IWD2022 – a day that shines a spotlight on how we can strive for a world that’s more diverse, equitable and inclusive. It’s a day that recognises the achievements of women, and a world where difference is valued and celebrated!
In recognition of the day, we spoke to some of the inspiring women we work with and invited them to share their views on how we can all take action for a gender equal world in order to #BreakTheBias.
You can find out more about International Women’s Day by visiting https://www.internationalwomensday.com
Learn more about HaemaLogix’s ground-breaking KappaMab technology
IRD Invest - Innovation and change
IRD Invest is a virtual investor conference series hosted by IR Department to showcase emerging companies, and to provide an additional value-add for our investor and client networks.
Surge in growth stocks lifts investor relations activity
2021 has been a record year for the number of initial public offerings (IPOs), with more than 130 on the ASX so far and dozens more anticipated by the end of December. The heightened IPO activity was fuelled by strong investor demand across a broad range of sectors. Led by resources, healthcare and technology stocks, it’s been the biggest global IPO surge in more than 20 years.
Atomo Diagnostics (ASX: AT1) presents at IRD Invest
IRD Invest is a virtual investor conference series hosted by IR Department to showcase emerging companies, and to provide an additional value-add for our investor and client networks.
We are all part of a new era. After reaching a low point in mid-2020, the investment landscape has changed dramatically. Companies, like investment markets, are adapting. We want to illustrate how our clients deal with change and provide fresh solutions to assist mitigate the effects of change.
Our third IRD Invest virtual investor conference ran over two days in late September 2021. We heard from a range of ASX listed companies that are innovating by addressing evolving consumer trends and patient needs.
What will investors be looking out for this reporting period?
With another financial reporting season upon us, we thought it an opportune time to consider what the investment community will likely be focusing on as they contemplate how best to position their portfolios over the next 6-12 months.
The evolution of social media in crisis communications - Part Two: When the crisis hits
Following on from where I left off in Part One of this blog, which looked at the evolution of social media in crisis management and five key steps to prepare your company before a crisis hits, today’s blog deals with strategies to help mitigate damage once an issue has hit.
The evolution of social media in crisis communications – Part One: Pre-crisis planning
In the world of issues and crisis management, today’s landscape is dramatically different to that of just a few years ago. Today we are living in a society of digitally enabled, always-on, constantly connected consumers with a multitude of smart devices at their fingertips.
ASEAN Dengue Day: Island Pharmaceuticals Investor briefing video
CEO and Managing Director at Island Pharmaceuticals Dr David Foster, Executive Chairman Dr Paul MacLeman, and Infectious Disease expert Prof Stephen Thomas MD discuss the most current understanding of the impact of dengue fever on the global community, the pace of growth in the ASEAN region and the changing battle against dengue in light of climate change and COVID-19.
Are you ready for the 2022 Financial Year? What you need to know and trends to watch out for.
End of Financial Year is a great time for investors to take stock and plan for the coming 12 months.
IR Department Account Director Juliana Roadley speaks to Morgans Reynolds Securities Private Client Adviser Patricia Tsicalas about the year that was 2021, as well as what to expect and how to prepare for the year ahead – covering one of the hottest topics going at the moment, the Australian Government’s upcoming changes to superannuation.
Three takeaways from the 2021 AIRA conference
The Australasian Investor Relations Association's (AIRA) annual conference is a great place to hear new ideas, exchange views, and reconnect with colleagues.
IR Department's Account Director, Juliana Roadley, attended this year’s conference in person. Here are her three clear takeaways:
Earned vs Bought media: Is it worth paying for a headline?
A media landscape dominated by digital is characterised by a lot of space, a lot of noise, and a lot of competition for air time. It’s tempting to consider paying for a headline… but is the cost worth it? We share our experience.
No-Nonsense Guide to Building a Social Media Strategy
We came across this insightful piece by IRM that covers the social media strategy must haves.
The "No-Nonsense Guide to Building a Social Media Strategy" covers defining your social media goals and it's audience and how to engage so your strategy is doing more than just making noise.
International Women's Day 2021 #GenerationEquality
March 8th is International Women's Day and in 2021, the theme is #GenerationEquality.
Equality is an important topic for us at IR Department. We work hard to be fair and equal across genders and races, in finding opportunities for our people and striving to win share of voice for our clients, who are often smaller fish, swimming in a sea of salmon and sharks.
On this #IWD2021, a few of our own brilliant women took a moment to share a quote an inspirational woman in their lives. We hope you enjoy the collection!
Biotech 2020
Thanks to all those presenters and investors who made time to attend IRD Invest, IR Department’s virtual investor conference on 29 July 2020.